GoodRx Holdings Enhances Investor Engagement Amid Rising Demand for Prescription Savings

GoodRx Expands Investor Engagement Amid Growing Demand for Prescription Savings

GoodRx Holdings, Inc. actively enhances its investor engagement by participating in two significant healthcare conferences scheduled for November and December 2024. The company’s executives will engage with the investor community during a fireside chat at the UBS 2024 Global Healthcare Conference in Rancho Palos Verdes, California, on November 12, and at the Citi 2024 Global Healthcare Conference in Miami, Florida, on December 5. These events underscore GoodRx's commitment to transparency and open communication with investors, providing a platform to discuss its innovative approaches to prescription savings and healthcare affordability. Live webcasts of these discussions will be available on GoodRx’s Investor Relations website, with recordings accessible for at least 30 days thereafter, ensuring that stakeholders can stay informed about the company's strategic direction.

GoodRx stands out in the U.S. healthcare landscape, serving over 25 million consumers and 750,000 healthcare professionals annually. Since its establishment in 2011, the company has facilitated substantial savings on prescriptions, amounting to over $75 billion. By offering discounts across more than 70,000 pharmacies nationwide, GoodRx positions itself as a vital resource for individuals seeking affordable medication options. The company's platform not only provides savings but also equips users with essential information regarding medication costs and options, which is crucial in an era where healthcare expenses continue to rise.

The commitment of GoodRx to enhancing healthcare affordability is pivotal as the landscape evolves. By participating in these conferences, the company aims to reinforce its role as a leader in the prescription savings market, while simultaneously fostering a culture of engagement with its investors. This proactive approach not only helps meet regulatory obligations but also serves to build trust and transparency within the investor community. As GoodRx continues to innovate and adapt to the changing healthcare environment, its efforts to keep investors informed and engaged will likely play a crucial role in its sustained success.

In addition to its participation in the upcoming investor conferences, GoodRx encourages stakeholders to regularly check its website for updates and disclosures related to its operations. The information provided serves as a valuable resource for investors looking to gain deeper insights into the company's performance and future developments. As GoodRx reinforces its leadership in prescription savings, its focus on communication and transparency remains a cornerstone of its strategy.